Sodium benzoate - Excelsior
Alternative Names: EX-039; PURE SODIUM BENZOATE CAPSULES - ExcelsiorLatest Information Update: 02 Mar 2023
At a glance
- Originator Unknown
- Developer Excelsior
- Class Antidementias; Antifungals; Antipsychotics; Antiseptics; Benzoates
- Mechanism of Action Ammonia scavengers; D amino acid oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Alzheimer's disease
Most Recent Events
- 08 Aug 2022 Phase-II clinical trials in Alzheimer's disease in Taiwan (PO, Capsule) (NCT05413655)
- 10 Jun 2022 Excelsior and Formosa Biomedical Technology plans a phase II trial in Alzheimer Disease (Adjunctive treatment, In adults, In the elderly) in June 2022 (PO, capsule) (NCT05413655)